Largescale Real-World Migraine Study Solidifies Efficacy and Safety of Theranica’s Nerivio® Device

Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced the publication of a new real-world post-marketing surveillance study in Pain Medicine that demonstrates the safety, efficacy and consistency of the company’s Nerivio^® therapeutic wearable device. Full story.